Smith Group Asset Management, LLC Corcept Therapeutics Inc Transaction History
Smith Group Asset Management, LLC
- $1.33 Trillion
- Q1 2025
A detailed history of Smith Group Asset Management, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Smith Group Asset Management, LLC holds 9,019 shares of CORT stock, worth $636,470. This represents 0.08% of its overall portfolio holdings.
Number of Shares
9,019
Previous 15,408
41.47%
Holding current value
$636,470
Previous $776 Million
32.68%
% of portfolio
0.08%
Previous 0.06%
Shares
7 transactions
Others Institutions Holding CORT
# of Institutions
477Shares Held
84MCall Options Held
1.43MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.17 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$704 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.74MShares$546 Million29.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$434 Million1.13% of portfolio
-
Parallel Advisors, LLC3.97MShares$280 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.56B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...